Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses

Journal of Gastroenterology and Hepatology (Australia)

Volumn 33, Issue 10, 2018, Pages 1751-1760

  Shen, Zhaohua ^a,b   Zhu, Changxin ^a,b   Quan, Yongsheng ^a,b   Yang, Jinming ^c   Yuan, Wei ^a,b   Yang, Zhenyu ^a,b   Wu, Shuai ^a,b   Luo, Weiwei ^a,b   Tan, Bei ^a,b   Wang, Xiaoyan ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Key Laboratory of Nonresolving Inflammation and Cancer   (China)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Crohn's disease; R. intestinalis; TGF ; Treg cells; TSLP

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PROBIOTIC AGENT; RNA 16S; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; CYTOKINE;

ACTINOMYCETACEAE; ACTINOMYCETALES; ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACILLI; BACTERIAL GENOME; BACTEROIDALES; BACTEROIDES; CACO-2 CELL LINE; CLINICAL ARTICLE; CLOSTRIDIALES; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ACTIVITY; ENTEROBACTERIACEAE; ENTEROBACTERIALES; ENTEROCOCCACEAE; EXPERIMENTAL COLITIS; FECES ANALYSIS; FEMALE; FLOW CYTOMETRY; FUSOBACTERIA; FUSOBACTERIACEAE; FUSOBACTERIALES; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLALES; LYMPHOCYTIC INFILTRATION; MALE; MICROCOCCACEAE; MORAXELLACEAE; MOUSE; MYXOCOCCALES; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PORPHYROMONADACEAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOBACTERIA; REGULATORY T LYMPHOCYTE; RIKENELLACEAE; ROSEBURIA INTESTINALIS; SPHINGOMONADACEAE; SPHINGOMONADALES; SPIROCHETE; THERMOMONOSPORACEAE; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS; WESTERN BLOTTING; YOUNG ADULT; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; ANIMALS; CACO-2 CELLS; CELL DIFFERENTIATION; CLOSTRIDIALES; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 85046497522     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.14144     Document Type: Article

References (28)

1. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 2015; 12: 205–217.
2. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46–54.
3. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620–625.
4. Atarashi K, Tanoue T, Oshima K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232–236.
5. Willing BP, Dicksved J, Halfvarson J et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844–1854.
6. Gevers D, Kugathasan S, Denson LA et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382–392.
7. Machiels K, Joossens M, Sabino J et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63: 1275–1283.
8. Tilg H, Danese S. Roseburia hominis: a novel guilty player in ulcerative colitis pathogenesis? Gut 2014; 63: 1204–1205.
9. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007; 2: 541–546.
10. Zhou Y, Zeng Z, Zhang W et al. Lactotransferrin: a candidate tumor suppressor—deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int. J. Cancer 2008; 123: 2065–2072.
11. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993; 72: 2979–2985.
12. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of bifi dobacterium adolescentis and faecalibacterium prausnitzii. Br. J. Nutr. 2009; 101: 533–542.
13. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 2005; 71: 3692–3700.
14. Foligne B, Nutten S, Grangette C et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 2007; 13: 236–243.
15. Xiao HT, Lin CY, Ho DH et al. Inhibitory effect of the gallotannin corilagin on dextran sulfatesodium-induced murine ulcerative colitis. J. Nat. Prod. 2013 Nov 22; 76: 2120–2125.
16. Alex P, Zachos NC, Nguyen T et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 2009; 15: 341–352.
17. Geng X, Xue J. Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease. Pak. J. Med. Sci. 2016; 32: 1164–1168.
18. Marteau P. Bacterial flora in inflammatory bowel disease. Dig. Dis. 2009; 27: 99–103.
19. Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 2003; 69: 4320–4324.
20. Qiu X, Zhang M, Yang X, Hong N, Yu C. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J. Crohns Colitis 2013; 7: 558–568.
21. Quevrain E, Maubert MA, Michon C et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65: 415–425.
22. Van den Abbeele P, Belzer C, Goossens M et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013; 7: 949–961.
23. Wang Y, Liu XP, Zhao ZB, Chen JH, Yu CG. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J. Dig. Dis. 2011; 12: 286–294.
24. Di Sabatino A, Biancheri P, Rovedatti L, MacDonald TT, Corazza GR. New pathogenic paradigms in inflammatory bowel disease. Inflamm. Bowel Dis. 2012; 18: 368–371.
25. Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig. Dis. Sci. 2011; 56: 376–386.
26. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 2005; 174: 3237–3246.
27. Pronio A, Montesani C, Butteroni C et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm. Bowel Dis. 2008; 14: 662–668.
28. Bi Y, Liu G, Yang R. Reciprocal modulation between TH17 and other helper T cell lineages. J. Cell. Physiol. 2011; 226: 8–13.